BRCA2 and endometrial cancer: By comparing the clinical and anamnestic characteristics of BRCA2 variants carriers vs. non-carriers, we observed that PanC patients with mutations in BRCA2 were more likely to have a family history for endometrial cancer (50%) compared to the non-carriers (4.3%), p = 0.018 (Additional file 1: Table S4).